CA9 and cancer: More importantly, the combination of CA IX inhibition by AZ and synergistic PTT/TDT possessed incomparable therapeutic advantages over traditional (ROS-mediated) cancer treatment in suppressing the growth of both hypoxic tumors and metastases hypoxic tumors.